Contact this trialFirst, we need to learn more about you.
Immunosuppressant
LP-10 for Hemorrhagic Cystitis
Recruiting1 awardPhase 2
Troy, Michigan
This trial will assess the safety and tolerability of three doses of LP-10 (intravesical tacrolimus). 12 subjects will be enrolled and treated in a prospective and multi-center trial. 4 subjects will be allocated into each one of three groups.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.